RTI Surgical Hits New 12-Month High at $5.45 (RTIX)
Shares of RTI Surgical (NASDAQ:RTIX) hit a new 52-week high during mid-day trading on Monday , Analyst Ratings News reports. The company traded as high as $5.45 and last traded at $5.32, with a volume of 350,284 shares changing hands. The stock had previously closed at $4.86.
A number of research firms have recently commented on RTIX. Analysts at Zacks upgraded shares of RTI Surgical from a “neutral” rating to an “outperform” rating in a research note on Monday, July 28th. They now have a $5.10 price target on the stock. Analysts at Canaccord Genuity raised their price target on shares of RTI Surgical from $5.00 to $7.00 in a research note on Friday, July 25th.
The stock has a 50-day moving average of $4.55 and a 200-day moving average of $4.19. The company’s market cap is $298.5 million.
RTI Surgical (NASDAQ:RTIX) last announced its earnings results on Thursday, July 24th. The company reported $0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.01. The company had revenue of $66.00 million for the quarter, compared to the consensus estimate of $59.20 million. The company’s revenue for the quarter was up 56.0% on a year-over-year basis. Analysts expect that RTI Surgical will post $0.10 EPS for the current fiscal year.
RTI Surgical Inc is engaged in processing human musculoskeletal and other tissue. It also processes bone, cartilage, tendon, ligament, fascia lata, pericardium, sclera and dermal tissue, and bovine animal tissue in producing allograft and xenograft implants utilizing BIOCLEANSE and TUTOPLAST sterilization processes, for distribution to hospitals and surgeons.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.